113 related articles for article (PubMed ID: 8596564)
21. [Serious side effects of sulfadoxine/pyrimethamine as antimalarials].
Christensen PK; Loft S; Olsen VV
Ugeskr Laeger; 1983 Jan; 145(4):245. PubMed ID: 6845486
[No Abstract] [Full Text] [Related]
22. [Granulomatous hepatitis attributed to the combination pyrimethamine-chloroquine].
van Everdingen-Bongers JJ; Janssen P; Lammens M; Stricker BH; Bravenboer B
Ned Tijdschr Geneeskd; 1996 Feb; 140(6):320-2. PubMed ID: 8720707
[TBL] [Abstract][Full Text] [Related]
23. [Drug-induced hepatitis caused by Fansidar].
Gersch K; Bröker HJ; Mörl H; Waldherr R
Schweiz Med Wochenschr; 1987 Oct; 117(40):1544-8. PubMed ID: 3118458
[TBL] [Abstract][Full Text] [Related]
24. [The reliability and side effects of malaria chemoprophylaxis].
Steffen R; Heusser R
Schweiz Rundsch Med Prax; 1986 Apr; 75(16):446-8. PubMed ID: 2939527
[No Abstract] [Full Text] [Related]
25. Agranulocytosis associated with malaria prophylaxis with Maloprim.
Friman G; Nyström-Rosander C; Jonsell G; Björkman A; Lekås G; Svendsrup B
Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1244-5. PubMed ID: 6404407
[No Abstract] [Full Text] [Related]
26. [Side effects of treatment with sulfones].
Revuz J; Hornac P
LARC Med; 1981 Dec; 1(3):68-70. PubMed ID: 6298511
[No Abstract] [Full Text] [Related]
27. The phenytoin syndrome.
Tomsick RS
Cutis; 1983 Dec; 32(6):535-41. PubMed ID: 6227459
[TBL] [Abstract][Full Text] [Related]
28. [Lansoprazole hypersensitivity syndrome].
Baudot S; Milpied-Homsi B; Andres P; Poirier Y; Larousse C
Therapie; 1999; 54(4):491-3. PubMed ID: 10667118
[No Abstract] [Full Text] [Related]
29. Dapsone hypersensitivity syndrome.
Prussick R; Shear NH
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):346-9. PubMed ID: 8698924
[TBL] [Abstract][Full Text] [Related]
30. [Is the use of Fansidar as an antimalarial justified?].
Olsen VV
Ugeskr Laeger; 1985 Feb; 147(7):624-5. PubMed ID: 3976083
[No Abstract] [Full Text] [Related]
31. [Acute hepatitis following administration of fansidar].
Meier P; Schmid M; Stäubli M
Schweiz Med Wochenschr; 1990 Feb; 120(7):221-5. PubMed ID: 2309111
[TBL] [Abstract][Full Text] [Related]
32. Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.
Lee PS; Lau EY
Br Med J (Clin Res Ed); 1988 Mar; 296(6626):893-5. PubMed ID: 3129063
[TBL] [Abstract][Full Text] [Related]
33. Agranulocytosis associated with maloprim: review of cases.
Hutchinson DB; Whiteman PD; Farquhar JA
Hum Toxicol; 1986 Jul; 5(4):221-7. PubMed ID: 3733111
[TBL] [Abstract][Full Text] [Related]
34. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
35. [Severe drug hypersensitivity reaction (DRESS syndrome) to doxycycline].
Mailhol C; Tremeau-Martinage C; Paul C; Godel A; Lamant L; Giordano-Labadie F
Ann Dermatol Venereol; 2010 Jan; 137(1):40-3. PubMed ID: 20110067
[TBL] [Abstract][Full Text] [Related]
36. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis.
Shapiro LE; Knowles SR; Shear NH
J Am Acad Dermatol; 1998 Jan; 38(1):132-3. PubMed ID: 9448227
[No Abstract] [Full Text] [Related]
37. Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
Reeve PA; Ala J; Hall JJ
J Trop Med Hyg; 1992 Aug; 95(4):266-70. PubMed ID: 1386634
[TBL] [Abstract][Full Text] [Related]
38. Drug interactions with antimalarial agents.
Griffin JP
Adverse Drug React Toxicol Rev; 1999 Mar; 18(1):25-43. PubMed ID: 10401521
[No Abstract] [Full Text] [Related]
39. Diphenylhydantoin-induced hepatitis: a case report.
Gloria L; Serejo F; Cruz E; Freitas J; Costa A; Ramalho F; Batista A; de Moura MC
Hepatogastroenterology; 1998; 45(20):411-4. PubMed ID: 9638415
[TBL] [Abstract][Full Text] [Related]
40. Diaminopyrimidines and severe cutaneous adverse reactions.
Feeney J
Arch Dermatol; 1997 Sep; 133(9):1173. PubMed ID: 9301603
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
